Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
"Beyond GLP-1: combination therapy for obesity and metabolic disease." Diabetes Obes Metab
[4] [5] The additional activation of GIP receptors may enhance insulin sensitivity and further support weight reduction
In adipose tissue, PYY (3-36) inhibits lipolysis, promotes lipid storage, and enhances systemic insulin sensitivity by regulating the secretion of fat factors such as adiponectin and leptin, thus improving insulin resistance and glucose homeostasis
At our clinic, we understand that nutrition needs vary during GLP-1 treatment
Enables studies on cardiometabolic health, metabolic regulation, and insulin sensitivity
US$ 23.93
US$ 24.79
US$ 29.27
US$ 27.81
US$ 26.89
US$ 20.56
